← 返回专利悬崖列表




替格瑞洛
Tier B · 提前布局Ticagrelor · 2029 年到期全部品种 →
阿斯利康
原研
2010
首批上市
2029
到期年(公开口径)
$1.59B ▲
峰值销售
化学药
类型
靶点:P2RY12
商品名:Brilinta、Possia、倍林达、Brilinta/Brilique、Brilique
适应症(已批准):中风、急性冠脉综合征、心肌梗塞、外周血管疾病
各地区研发/上市状态
美国
批准上市
2011-07-20
欧盟
批准上市
2010-12-03
中国
批准上市
2012-11-22
日本
批准上市
2016-09-28
合成路线与中间体5 routes
原研路线 × 1优化路线(非专利)× 4工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 9 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TICA-001 | 145783-14-8在售 | 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| TICA-002 | 155899-66-4在售 | (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol |
| TICA-003 | 220241-59-8在售 | (3aR,4S,6R,6aS)-6-((6-chloro-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol |
| TICA-004 | 220241-60-1在售 | (3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol |
| TICA-005 | 220241-61-2在售 | (3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol |
| TICA-006 | 274693-22-0在售 | (3aR,4S,6R,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol |
| TICA-007 | 88016-31-3在售 | methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate |
| TICA-008 | 274693-23-1在售 | methyl 2-(((3aR,4S,6R,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate |
| TICA-009 | 274693-24-2在售 | methyl 2-(((3aR,4S,6R,6aS)-6-(7-bromo-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate |
| TICA-010 | 220352-38-5在售 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine |
| TICA-011 | 274693-25-3在售 | methyl 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate |
| TICA-012 | 30472-97-0在售 | potassium sodium (2R,3R)-2,3-dihydroxysuccinate |
| TICA-013 | 274693-26-4在售 | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
| TICA-014 | 60410-16-4在售 | (1R,4S)-4-hydroxycyclopent-2-en-1-yl acetate |
| TICA-015 | 51779-32-9在售 | - |
| TICA-016 | 220241-57-6在售 | - |
| TICA-017 | 7529-22-8在售 | 4-methylmorpholine 4-oxide |
| TICA-018 | 220241-58-7在售 | - |
| TICA-019 | 77-76-9在售 | 2,2-dimethoxypropane |
优化Route 2步骤 9 · 总收率 19 mg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TICA-010 | 220352-38-5在售 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine |
| TICA-013 | 274693-26-4在售 | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
| TICA-020 | 2171459-69-9在售 | 6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one |
| TICA-021 | 107-08-4在售 | 1-iodopropane |
| TICA-022 | 145783-12-6在售 | 2-(propylthio)pyrimidine-4,6-diol |
| TICA-023 | 106-49-0在售 | p-toluidine |
| TICA-024 | 376608-72-9在售 | (E)-2-(propylthio)-5-(p-tolyldiazenyl)pyrimidine-4,6-diol |
| TICA-025 | 376608-73-0在售 | (E)-4,6-dichloro-2-(propylthio)-5-(p-tolyldiazenyl)pyrimidine |
| TICA-026 | 1415806-23-3在售 | 4,6-dichloro-2-(propylthio)-5-(2-(p-tolyl)hydrazinyl)pyrimidine |
| TICA-027 | 145783-15-9在售 | 4,6-dichloro-2-(propylthio)pyrimidin-5-amine |
| TICA-028 | 274693-55-9在售 | 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
| TICA-029 | 376608-74-1在售 | 2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
| TICA-030 | 376608-75-2在售 | 2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
优化Route 3步骤 7 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TICA-010 | 220352-38-5在售 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine |
| TICA-031 | 34036-07-2在售 | 3,4-difluorobenzaldehyde |
| TICA-032 | 141-82-2在售 | malonic acid |
| TICA-033 | 112897-97-9在售 | (E)-3-(3,4-difluorophenyl)acrylic acid |
| TICA-034 | 376608-66-1在售 | (E)-3-(3,4-difluorophenyl)acryloyl chloride |
| TICA-035 | 89-78-1在售 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol |
| TICA-036 | 376608-67-2在售 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (E)-3-(3,4-difluorophenyl)acrylate |
| TICA-037 | 376608-68-3在售 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate |
| TICA-038 | 220352-36-3在售 | (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylic acid |
| TICA-039 | 378236-67-0在售 | (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carbonyl azide |
优化Route 4步骤 5 · 总收率 192 mg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TICA-027 | 145783-15-9在售 | 4,6-dichloro-2-(propylthio)pyrimidin-5-amine |
| TICA-040 | 1068-90-2在售 | diethyl 2-acetamidomalonate |
| TICA-041 | 62-56-6在售 | thiourea |
| TICA-042 | 1549834-16-3在售 | sodium 5-acetamido-4,6-dihydroxypyrimidine-2-thiolate |
| TICA-043 | 133030-24-7在售 | N-(4,6-dihydroxy-2-mercaptopyrimidin-5-yl)acetamide |
| TICA-044 | 106-94-5在售 | 1-bromopropane |
| TICA-045 | 1549834-56-1在售 | N-(4,6-dihydroxy-2-(propylthio)pyrimidin-5-yl)acetamide |
| TICA-046 | 1549834-66-3在售 | 5-amino-2-(propylthio)pyrimidine-4,6-diol hydrochloride |
优化Route 5步骤 9 · 总收率 0.48 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TICA-001 | 145783-14-8在售 | 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| TICA-010 | 220352-38-5在售 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine |
| TICA-047 | 866551-95-3在售 | ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate |
| TICA-048 | 1612796-22-1在售 | ethyl 2-(((1S,2S,3S,4R)-4-(((benzyloxy)carbonyl)amino)-2,3-dihydroxycyclopentyl)oxy)acetate |
| TICA-049 | 1612796-23-2在售 | ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2-oxotetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate |
| TICA-050 | 1612796-24-3在售 | benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2-oxotetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)carbamate |
| TICA-051 | 1612796-25-4在售 | (3aS,4R,6S,6aR)-4-amino-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one |
| TICA-052 | 1612796-35-6在售 | (3aS,4R,6S,6aR)-4-((6-chloro-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one |
| TICA-053 | 1482484-91-2在售 | (3aS,4R,6S,6aR)-4-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one |
| TICA-054 | 1612796-36-7在售 | (3aS,4R,6S,6aR)-4-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one |
| TICA-055 | 1612796-37-8在售 | (3aS,4R,6S,6aR)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one |
常见问题(FAQ)
替格瑞洛的适应症有哪些?
已批准的适应症包括:中风、急性冠脉综合征、心肌梗塞、外周血管疾病。
替格瑞洛的专利什么时候到期?
按公开口径,替格瑞洛的专利到期年为 2029 年。
替格瑞洛有几条合成路线?
本站收录 5 条合成路线,最短路线 5 步、总收率 192 mg。每条路线的中间体均带登记编号与 CAS 号。
替格瑞洛的关键中间体在哪里可以采购?
替格瑞洛的多条路线中间体已挂接 CAS 档案,其中 55 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取替格瑞洛中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24